Melinta Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Melinta Therapeutics, Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Melinta Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Melinta Therapeutics, Inc..